LabCorp, Roche, UNMC, Affymetrix, Applera, Functional Genomics Center of Zurich, Rosetta, Canada | GenomeWeb

LabCorp to Sell Roche's AmpliChip CYP450 Assay

Laboratory Corporation of America will sell Roche Diagnostics' Amplichip Cytochrome P450 2D6/2C19 genotyping and phenotyping assay, the company said this week.

The assay was approved by the US Food and Drug Administration in January, and is designed to identify multiple genetic variants in two cytochrome P450 genes, CYP2D6 and CYP2C19, which metabolize 40 to 45 percent of all prescription drugs, including antidepressants, pain relievers, and cardiovascular agents (see BAN 1/5/2005).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.